- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03460626
Evaluation of Aromatherapy on Academic Stress ((EAS))
Evaluation of Aromatherapy on Academic Stress: A Randomized Placebo Controlled Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Stress is a disorder that affects human feelings through disturbance in behavior, thinking and mood. The mood disturbances further leads to mental, physical and emotional problems which affects the learning as well as thinking capabilities of individuals.Work load i.e. preparing for exams along with acquisition of knowledge, skills and attitudes have been reported as more stressful to cope up with, during university life of medical students. Exam load is reported as a major stressor and a number of studies have reported a suffering of 30% medical students due to exam stress. whereas some studies have reported a high stress level in 80% of college students during exams. No significant difference is observed for gender with regard to level of stress during exams. Besides course loads, exams, quizzes and busy schedule, academic competition among students for higher grades also promotes stress. This academic competition in students may sometimes be unavoidable. Alternative treatment namely aromatherapy, hydrotherapy and homeopathy are employed to reduce stress.
Aromatherapy is one of the alternative treatments in which oils extracted from natural sources such as flowers, petals and bark of plants are used to enhance the physical and psychological conditions of individuals. Various naturally extracted aromatic essences are applied in order to balance cognitive functions and memory retention. The aromatic essences/oils used in aromatherapy such as lavender oil, rosemary oil, jasmine oil, peppermint oil etc. are believed to stimulate cognitive function and are used for purposes of pain relieving, mood enhancement. Among these essences, lavender oil has been applied predominantly in oral administration, aromatherapy as well as massage therapy in many clinical studies exhibiting positive outcomes. Lavender oil reduces stress and produce relaxation via limbic system, particularly the amygdala and hippocampus.
A comparative study in 36 volunteers showed a reduced stress level in group using lavender oil as aromatherapy as compared to placebo group. Another study at Hong Kong University revealed the fact that aromatherapy may be utilized as an effective tool in order to alleviate pain, reduce depression and level of stress in older adults. A study in Iran among students, showed reduction in test-related anxiety with the use of Polianthes tuberosa essential oils. Similar study in students of Florida Atlantic University observed the vital effects of aroma oils and recommended the use of rosemary and lavender oil during exam for reducing stress level. In addition, lavender oil as stress reducer and leading towards relaxation during exam stress has been reported. Lavender oil as a cream along with a foot-bath, may be used in pregnant as well as non-pregnant females even, in order to reduce stress and anxiety. Based on aforementioned results, lavender oil may be effectively used to reduce the level of stress, produced due to any factor. However, none of the studies have reported the use of lavender oil in pharmacy students particularly during exams.
This study is aimed to target Pharmacy students at Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia in order to evaluate the effect of aromatherapy i.e. lavender oil in stress among students during exams.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Eastern Province
-
Dammam, Eastern Province, Saudi Arabia, 31441
- College of Clinical Pharmacy
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The study includes only male student of Pharmacy college at IAU.
- Students from 2nd to 5th year are eligible for the study.
- All the students who are willing to participate voluntarily and are in healthy state will be included in the study.
Exclusion Criteria:
- Students from other colleges as well as female students are not included in the study.
- Any student who have no consent to participate will be excluded from this study.
- Students with a history of stress, anxiety and depression, with any serious chronic medical conditions, any known allergy to aromatherapy or lavender oil.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Group-I (Control group)
This group will be administered a placebo that is an odorless oil without any therapeutic effect)
|
an odorless oil without any therapeutic effect
Other Names:
|
Experimental: Group-II (Treated group)
This group will be administered lavender oil.
|
The oil used in this study will be lavender oil with a final concentration of 3% using almond oil (90%) as diluent.
The oil after dilution and final preparation will be converted to proper clean vial in a fix amount (10 ml) and given to the students.
|
No Intervention: Group-III (Untreated group)
No intervention will be provided in this group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline perceived academic stress at day 7 and at day 14
Time Frame: Day 1 to day 7 till day 14
|
For investigating the level of stress during examination, a subjective perceived stress scale would be given to students to report perceived academic stress.
The range of this scale is from 0 to 5 where a value of 0 indicate no academic stress and value of 5 indicate severe academic stress.
|
Day 1 to day 7 till day 14
|
Change in baseline mean Blood pressure at day 7 and at day 14
Time Frame: Day 1 to day 7 till day 14
|
For observing any change in mean blood pressure, a blood pressure monitor will be used to determine any variation in blood pressure in millimeters of mercury (mm of Hg).
A total of three readings will be taken at baseline day 0, day 7 and day 14.
The mean value obtained from three readings will be considered final for each time point.
|
Day 1 to day 7 till day 14
|
Change in baseline heart rate at day 7 and at day 14
Time Frame: Day 1 to day 7 till day 14
|
For observing any change in heart rate, a blood pressure monitor will be used to determine change in heart rate in beats per minute (BPM).
A total of three readings will be taken at baseline, day 7 and day 14.
The mean value obtained from three readings will be considered final for each time point.
|
Day 1 to day 7 till day 14
|
Change in baseline Stool consistency at day 7 and day 14
Time Frame: Day 1 to day 7 till day 14
|
Bristol stool chart (BST) to indicate the consistency and frequency of stools passed during this period.
Bristol stool chart consists of 7 types of stools.
It is a subjective assessment.
|
Day 1 to day 7 till day 14
|
Change in baseline headache at day 7 and day 14
Time Frame: Day 1 to day 7 till day 14
|
visual analog scale (VAS) for recording the intensity of headache experienced by students during this period.
Visual Analogue Scale consist of a range of 1 to 5. (1 = normal and 5 = extreme).
It is a subjective self reporting instrument.
|
Day 1 to day 7 till day 14
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Dr Mastour S Al Ghamdi, PhD, Dean, College of Clinical Pharmacy
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IAU-ATCT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
- Clinical Study Report (CSR)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...Enrolling by invitationStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
University of PadovaRecruitingStress | Stress Disorder | Work Related StressItaly
-
Duquesne UniversityUniversity of California, San Diego; West Penn Allegheny Health System; El Centro... and other collaboratorsTerminated
-
University of Sao PauloCompleted
-
Syracuse VA Medical CenterUS Department of Veterans AffairsCompletedEmotional Stress | Psychological Stress | Life StressUnited States
-
Dana-Farber Cancer InstituteEnrolling by invitationStress | Post Traumatic Stress Disorder | Work Related StressUnited States
-
Taichung Veterans General HospitalUnknown
-
Royal Cornwall Hospitals TrustEnrolling by invitationStress | Stress, Psychological | Stress, JobUnited Kingdom
-
Northumbria UniversityVolac International LtdNot yet recruitingStress | Mood | Physiological Stress
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
ItalfarmacoCompletedBecker Muscular DystrophyNetherlands, Italy
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States